This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Regulus Therapeutics Inc (RGLS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 17.81M 40.55M 9.18M
Receivables 79.00K 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 117.18M 98.93M 38.67M
Property, Plant & Equipment, Gross 7.50M 5.75M 4.61M
Accumulated Depreciation & Depletion 3.73M 2.44M 1.50M
Property, Plant & Equipment, Net 3.77M 3.31M 3.11M
Intangibles 1.13M 1.15M 980.00K
Other Non-Current Assets 987.00K 125.00K 125.00K
Total Non-Current Assets 5.88M 4.59M 4.22M
Liabilities & Shareholder Equity
Total Assets 123.06M 103.52M 42.88M
Accounts Payable 1.17M 311.00K 501.00K
Short Term Debt 0.00 0.00 377.00K
Other Current Liabilities 0.00 0.00 206.00K
Total Current Liabilities 10.37M 12.77M 12.85M
Long Term Debt 11.28M 10.13M 10.00M
Deferred Income Taxes 0.00 0.00 446.00K
Other Non-Current Liabilities 7.96M 18.52M 17.95M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 19.24M 28.66M 71.52M
Total Liabilities 29.61M 41.42M 84.38M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 93.46M 62.09M -41.49M
Common Par 42.00K 36.00K 0.00
Additional Paid In Capital 172.52M 122.53M 1.58M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -79.09M -60.42M -43.01M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -16.00K -52.00K -67.00K
Total Capitalization 104.74M 72.23M -31.49M
Total Equity 93.46M 62.09M -41.49M
Total Liabilities & Stock Equity 123.06M 103.52M 42.88M
Total Common Shares Outstanding 41.79M 35.83M 34.13M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 38.48M 8.21M 15.18M
Diluted Weighted Shares Outstanding 38.48M 8.21M 15.18M
Number of Employees 76 66 NA
Number of Part-Time Employees 0 6 NA
RGLS News

RGLS Regulus Therapeutics Inc

Analysts Ratings for RGLS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RGLS ANALYST REPORT

Brokerage Partners

RGLS Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs